Pharmacokinetic study of IV infusions of adriamycin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic study of IV infusions of adriamycin

Published:1985 Issue:2 Volume:28 Page:205-212
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Eksborg S.,Strandler H. -S.,Edsmyr F.,N�slund I.,Tahvanainen P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00609693.pdf

Reference42 articles.

1. Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Int Med 80: 249?259

2. Carter SK (1975) Adriamycin ? A review. J Natl Cancer Inst 55: 1265?1274

3. Lenaz L, Page JA (1976) Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3: 111?120

4. Minow RA, Benjamin RS, Lee ET, Gottlieb JA (1977) Adriamycin cardiomyopathy-risk factors. Cancer 39: 1397?1402

5. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, von Hoff Al, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Int Med 91: 710?717

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A physiologically-based pharmacokinetic model for predicting doxorubicin disposition in multiple tissue levels and quantitative toxicity assessment;Biomedicine & Pharmacotherapy;2023-12

2. A comparative study between conventional chemotherapy and photothermal activated nano-sized targeted drug delivery to solid tumor;Computers in Biology and Medicine;2023-11

3. SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species;2023-03-29

4. Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment;Biomedical and Pharmacology Journal;2022-09-29

5. Population pharmacokinetics of doxorubicin: A systematic review;Asia-Pacific Journal of Clinical Oncology;2022-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3